List of tables

Table 2.2.1. Responses by country. Numbers of respondents (total) and respondents using genetic modification are listed by country 59

Table 2.2.2. Traits targeted in genetic modification projects, in laboratory based experiments 61

Table 2.2.3. Traits/genes targeted in projects with GM trees in field trials 62

Table 2.2.4. Established field trials of GM trees¹ 63

Table 2.2.5. Issues addressed in field trials with GM trees (number of projects addressing a particular issue) 64

Table 2.2.6. Involvement of regulatory agencies in pre-risk assessments of genetic modification projects, surveillance, monitoring and quarantine (S/M/Q) and management of failure, redress, control (M/R/C), by country¹. 67

Table 2.2.7. GM tree projects for which regulatory approval is currently sought 67

Table 2.2.8. Commercial benefits anticipated from GM trees 71

Table 2.2.9. Environmental benefits expected from GM trees 72

Table 2.2.10. Human health benefits expected from GM trees 73

Table 2.2.11. Anticipated commercial risks of GM trees 74

Table 2.2.12. Anticipated human health risks of GM trees 75

Table 2.2.13. Anticipated environmental risks of GM trees 76

Table 2.2.14. How risks involved with tree genetic modification can be addressed 78

Table 2.2.15. Obstacles to the use of genetic modification in trees. Most respondents identified more than one obstacle 81

Table 2.2.16. Field trials of GM forest trees and GM ornamental/fruit trees recorded in publicly available databases, by country 85

Table 2.2.17. Field trials with GM forest trees and fruit trees/ornamentals 86

Table 2.2.18. Genes and traits related to field tests 87

Table 2.3.1. Summary of species and status of R&D on genetic modification in forest trees in China 103

Table 2.4.1. Current global applications and projected future importance and trends of forest tree biotechnology 114

Table 2.4.2. Anticipated contribution to and scale of impact of each broad area of biotechnology on elements of natural and artificial forest populations 116